Stocks vs. Options: Which generates better returns?
Plug in your stock idea to find options trades offering a potentially better ROI.
NEW TO OPTIONS?
Visit our New to Options page to learn more.
Find out more »
It’s just another merger Monday for Johnson & Johnson (JNJ), Xerox (XRX), and Abbott Laboratories (ABT)
Beth Gaston Moon is the Senior Editor for the Options News Network. Beth was a member of the research department at Schaeffer's Investment Research for more than a decade. September 28, 2009 8:00 EDT Related Symbols: ABT, ACS, CRXL, JNJ, XRX
Stock index futures are currently up five-and-a-half points to 1,046.60. The S&P 500 closed Friday night at 1,044.38. Fair value basis is negative 4.37, so fair value of the futures is roughly 1,040.01. Overnight range of stock futures was 1,035.7 to 1,045.4.
International markets are mixed despite rallying futures; European indices are up nearly 1% while the Hong Kong Hang Seng closed off 2%; the Japanese Nikkei dropped 2.5% on the day.
It’s another merger Monday, with Abbott Laboratories (ABT) spending $7.1 billion on Solvay SA’s pharmaceutical unit, Xerox (XRX) buying Affiliated Computer Services (ACS) for $6.5 billion, and Johnson & Johnson (JNJ) planning to acquire an 18% stake in Crucell (CRXL).
Investors remain concerned over prospects for a fast recovery following last week’s G-20 summit that ended Friday. We do not expect any significant earnings announcements today. Stay tuned to ONN.tv for continued market updates as earnings season starts back up throughout the next couple months.
Two Traders, One Strategy Steve and Jared take a look at risk management strategies on the OH platform.
Navigating OptionsHouse Get to know the OH platform and all the tools you have at your disposal.